Increased PI3K/AKT/mTOR signaling activity in stroma/immune cells surrounding the tumor cells further validates the role of genomic-independent mechanisms within the tumor microenvironment as key regulators of the PI3K/AKT/mTOR signaling cascade. The gene discussed is PIK3CA; the disease is neoplasm.